H2561B3883A07134 AJB:JMT 09/14/20 #90 A07134
AMENDMENTS TO HOUSE BILL NO. 2561
Sponsor: REPRESENTATIVE SCHLEGEL CULVER
Printer's No. 3883
Amend Bill, page 2, line 1, by inserting after "of"
topical and oral
Amend Bill, page 2, lines 2 and 3, by striking out "Food and
Drug" in line 2 and all of line 3 and inserting
board as provided in section 4.3
Amend Bill, page 2, line 19, by striking out ", prevention"
Amend Bill, page 2, line 28, by inserting after "drugs"
, either by topical or oral routes of administration,
Amend Bill, page 2, lines 29 and 30, by striking out
"diseases and conditions affecting "
Amend Bill, page 2, line 30, by striking out "and adnexa"
Amend Bill, page 2, line 30, by inserting after "adnexa,"
the eyelids, the lacrimal system and the
conjunctiva ,
Amend Bill, page 3, line 1, by striking out the period after
"combinations" and inserting
, so long as the treatment of diseases or conditions
of the visual system, other than glaucoma, dry eyes or
allergies, as authorized under this paragraph shall not
continue beyond six weeks from the initiation of
treatment unless the prescribing optometrist documents
consultation with a licensed physician. As used in this
paragraph, the initiation of treatment may, but need not,
include the prescription or administration of
pharmaceutical agents for therapeutic purposes.
Amend Bill, page 3, line 4, by inserting after "bodies"
from the ocular surface or adnexa
2020/90AJB/HB2561A07134 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27